Profile data is unavailable for this security.
About the company
PT Tempo Scan Pacific Tbk is an Indonesia-based company engaged in the pharmaceuticals, consumer products, and cosmetics industry. The Company's segments include Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. The Pharmaceuticals segment conducts marketing of consumer health products, including over-the-counter drugs, vitamins, minerals and supplements (VMS), beverages, nutritional products, herbal products, and prescription medicines. The Consumer Products and Cosmetics segment markets and distributes its own branded products as well as licensed cosmetics products. The Distribution Services segment distributes products to customers and serves customers from various sales branches throughout Indonesia, covering pharma, modern trade, and general trade channels. It also markets and distributes its products overseas through its international business units. Its business network covers approximately 238 locations consisting of over 48 branches.
- Revenue in IDR (TTM)13.49tn
- Net income in IDR1.45tn
- Incorporated1971
- Employees4.46k
- LocationTempo Scan Pacific Tbk PTLantai 16, Tempo Scan TowerJl. HR. Rasuna Said Kav. 3-4JAKARTA 12950IndonesiaIDN
- Phone+62 2 129218888
- Fax+62 2 129209999
- Websitehttps://www.temposcangroup.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kyorin Pharmaceutical Co Ltd | 14.30tn | 999.11bn | 9.89tn | 2.00k | 9.48 | 0.6323 | 6.57 | 0.6912 | 158.16 | 158.16 | 2,264.40 | 2,372.28 | 0.7008 | 1.18 | 2.78 | 65,108,610.00 | 4.89 | 3.34 | 6.25 | 4.16 | 45.77 | 45.89 | 6.98 | 5.11 | 2.01 | -- | 0.1727 | 57.34 | 8.83 | 3.41 | 70.73 | 8.12 | 14.36 | -7.06 |
| Evolus Inc | 4.47tn | -911.05bn | 9.91tn | 372.00 | -- | -- | -- | 2.22 | -0.8883 | -0.8883 | 4.36 | -0.1025 | 1.25 | 8.14 | 6.74 | 829,707.80 | -25.57 | -37.04 | -33.40 | -57.14 | 68.14 | 65.19 | -20.40 | -51.26 | 2.16 | -2.20 | 1.06 | -- | 31.76 | 50.12 | 18.26 | -- | 1.10 | -- |
| Yabao Pharmaceutical Group Co Ltd | 5.72tn | 537.49bn | 9.97tn | 3.61k | 18.97 | 1.50 | -- | 1.74 | 0.3321 | 0.3321 | 3.56 | 4.20 | 0.6867 | 3.21 | 7.28 | 700,459.00 | 5.98 | 4.01 | 7.35 | 5.38 | 49.25 | 56.75 | 8.71 | 5.86 | 2.23 | 216.10 | 0.0308 | 54.27 | -7.69 | -2.46 | 21.60 | 77.16 | -26.08 | 71.88 |
| Zhejiang Starry Pharmaceutical Co Ltd | 5.41tn | -106.36bn | 10.04tn | 1.75k | -- | 1.68 | -- | 1.86 | -0.148 | -0.148 | 5.53 | 6.03 | 0.4134 | 1.93 | 5.36 | 1,364,778.00 | -0.8186 | 2.04 | -1.55 | 3.75 | 17.43 | 27.73 | -1.98 | 5.05 | 0.4403 | 0.4261 | 0.5086 | 78.73 | 7.02 | 12.42 | -211.00 | -- | 29.24 | -3.43 |
| Medincell SA | 202.13bn | -595.92bn | 10.05tn | 131.00 | -- | -- | -- | 49.73 | -1.08 | -1.08 | 0.3674 | -1.86 | 0.1951 | -- | 6.59 | -- | -57.52 | -- | -110.59 | -- | 91.60 | -- | -294.82 | -210.68 | -- | -1.66 | 10.71 | -- | 181.43 | 54.88 | 26.36 | -- | -- | -- |
| ZhuZhou QianJin Pharmaceutical Co., Ltd | 8.22tn | 537.53bn | 10.14tn | 5.27k | 18.52 | 1.81 | -- | 1.23 | 0.5787 | 0.5787 | 8.81 | 5.94 | 0.7733 | 3.85 | 9.44 | 689,580.10 | 6.68 | 8.36 | 12.20 | 15.33 | 45.72 | 44.74 | 8.64 | 9.71 | 1.51 | -- | 0.1071 | 67.36 | -4.44 | 0.5863 | -27.98 | -4.75 | 3.10 | -6.36 |
| Hunan Fangsheng Pharmaceutical Co Ltd | 3.97tn | 617.96bn | 10.22tn | 1.81k | 16.58 | 2.71 | -- | 2.57 | 0.6208 | 0.6208 | 4.00 | 3.79 | 0.5488 | 1.43 | 6.38 | 972,453.20 | 8.44 | 6.11 | 14.43 | 10.86 | 69.41 | 67.05 | 15.38 | 10.32 | 0.5111 | -- | 0.2722 | 49.73 | 9.15 | 10.20 | 36.61 | 26.46 | -13.82 | 38.88 |
| Sinovac Biotech Ltd | 6.96tn | -2.12tn | 10.37tn | 3.04k | -- | -- | -- | 1.49 | -1.31 | -1.31 | 4.31 | 86.81 | 0.0322 | 0.2019 | 1.08 | 141,325.00 | -2.23 | 36.14 | -3.30 | 58.37 | 92.09 | 90.77 | -69.19 | 65.87 | 11.24 | -- | 0.0262 | -- | -69.97 | 14.31 | -198.16 | -- | 91.80 | -- |
| Phathom Pharmaceuticals Inc | 1.33tn | -5.61tn | 10.39tn | 427.00 | -- | -- | -- | 7.83 | -5.24 | -5.24 | 1.23 | -4.86 | 0.2516 | 4.88 | 4.07 | 191,707.30 | -106.28 | -72.89 | -129.70 | -84.11 | 86.23 | -- | -422.42 | -1,799.61 | 3.54 | -4.82 | 2.50 | -- | 8,001.47 | -- | -65.84 | -- | 0.4505 | -- |
| Supriya Lifescience Ltd | 1.32tn | 355.00bn | 10.45tn | 448.00 | 29.44 | 5.55 | 26.56 | 7.95 | 23.36 | 23.36 | 86.55 | 123.85 | 0.685 | 2.07 | 5.66 | -- | 18.49 | 18.45 | 20.05 | 21.63 | 69.68 | 61.03 | 26.99 | 25.45 | 3.88 | 142.56 | 0.0054 | 3.59 | 22.11 | 17.45 | 57.80 | 20.69 | 45.94 | -- |
| Tempo Scan Pacific Tbk PT | 13.49tn | 1.45tn | 10.46tn | 4.46k | 7.20 | 1.15 | 5.32 | 0.7757 | 322.20 | 322.20 | 2,995.62 | 2,018.14 | 1.07 | 3.89 | 8.55 | 3,010,721,000.00 | 12.21 | 10.71 | 16.92 | 14.66 | 37.99 | 35.87 | 11.38 | 9.06 | 2.27 | -- | 0.1082 | 43.45 | 4.08 | 4.43 | 22.96 | 21.17 | 3.64 | 20.11 |
Data as of Jul 11 2025. Currency figures normalised to Tempo Scan Pacific Tbk PT's reporting currency: Indonesian Rupiah IDR
0.61%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 04 Jul 2025 | 11.48m | 0.26% |
| FIL Investment Management (Singapore) Ltd.as of 31 May 2025 | 9.36m | 0.21% |
| Grantham, Mayo, Van Otterloo & Co. LLCas of 28 Feb 2025 | 3.32m | 0.07% |
| Dimensional Fund Advisors Ltd.as of 04 Jul 2025 | 1.01m | 0.02% |
| FIL Investments Internationalas of 31 Mar 2025 | 674.60k | 0.02% |
| BN & Partners Capital AGas of 30 May 2025 | 600.00k | 0.01% |
| American Century Investment Management, Inc.as of 02 Jul 2025 | 359.30k | 0.01% |
| State Board of Administration of Florida Retirement Systemas of 31 Mar 2025 | 237.61k | 0.01% |
| PT Indo Premier Securities (Investment Management)as of 28 May 2025 | 235.77k | 0.01% |
| SLGI Asset Management, Inc.as of 31 Dec 2024 | 232.20k | 0.01% |
More ▼
Data from 31 Dec 2024 - 30 May 2025Source: FactSet Research Systems Inc.
